BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15355996)

  • 1. Targeted knockdown of the RNA-binding protein CRD-BP promotes cell proliferation via an insulin-like growth factor II-dependent pathway in human K562 leukemia cells.
    Liao B; Patel M; Hu Y; Charles S; Herrick DJ; Brewer G
    J Biol Chem; 2004 Nov; 279(47):48716-24. PubMed ID: 15355996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells.
    Liao B; Hu Y; Herrick DJ; Brewer G
    J Biol Chem; 2005 May; 280(18):18517-24. PubMed ID: 15753088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRD-BP/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells.
    Ioannidis P; Mahaira LG; Perez SA; Gritzapis AD; Sotiropoulou PA; Kavalakis GJ; Antsaklis AI; Baxevanis CN; Papamichail M
    J Biol Chem; 2005 May; 280(20):20086-93. PubMed ID: 15769738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRD-BP: a c-Myc mRNA stabilizing protein with an oncofetal pattern of expression.
    Ioannidis P; Mahaira L; Papadopoulou A; Teixeira MR; Heim S; Andersen JA; Evangelou E; Dafni U; Pandis N; Trangas T
    Anticancer Res; 2003; 23(3A):2179-83. PubMed ID: 12894594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammary tumor induction in transgenic mice expressing an RNA-binding protein.
    Tessier CR; Doyle GA; Clark BA; Pitot HC; Ross J
    Cancer Res; 2004 Jan; 64(1):209-14. PubMed ID: 14729626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA-binding protein insulin-like growth factor mRNA-binding protein 3 (IMP-3) promotes cell survival via insulin-like growth factor II signaling after ionizing radiation.
    Liao B; Hu Y; Brewer G
    J Biol Chem; 2011 Sep; 286(36):31145-52. PubMed ID: 21757716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-suppressive lipoxygenases inhibit the expression of c-myc mRNA coding region determinant-binding protein/insulin-like growth factor II mRNA-binding protein 1 in human prostate carcinoma PC-3 cells.
    Kawakami Y; Kubota N; Ekuni N; Suzuki-Yamamoto T; Kimoto M; Yamashita H; Tsuji H; Yoshimoto T; Jisaka M; Tanaka J; Fujimura HF; Miwa Y; Takahashi Y
    Biosci Biotechnol Biochem; 2009 Aug; 73(8):1811-7. PubMed ID: 19661680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human insulin-like growth factor II leader 2 mediates internal initiation of translation.
    Pedersen SK; Christiansen J; Hansen Tv; Larsen MR; Nielsen FC
    Biochem J; 2002 Apr; 363(Pt 1):37-44. PubMed ID: 11903044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the four leader sequences of the human insulin-like-growth-factor-2 mRNAs on the expression of reporter genes.
    De Moor CH; Jansen M; Bonte EJ; Thomas AA; Sussenbach JS; Van den Brande JL
    Eur J Biochem; 1994 Dec; 226(3):1039-47. PubMed ID: 7813458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of c-myc expression in cells by targeting an RNA-protein interaction using antisense oligonucleotides.
    Coulis CM; Lee C; Nardone V; Prokipcak RD
    Mol Pharmacol; 2000 Mar; 57(3):485-94. PubMed ID: 10692488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two Isoforms of the RNA Binding Protein, Coding Region Determinant-binding Protein (CRD-BP/IGF2BP1), Are Expressed in Breast Epithelium and Support Clonogenic Growth of Breast Tumor Cells.
    Fakhraldeen SA; Clark RJ; Roopra A; Chin EN; Huang W; Castorino J; Wisinski KB; Kim T; Spiegelman VS; Alexander CM
    J Biol Chem; 2015 May; 290(21):13386-400. PubMed ID: 25861986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental regulation of CRD-BP, an RNA-binding protein that stabilizes c-myc mRNA in vitro.
    Leeds P; Kren BT; Boylan JM; Betz NA; Steer CJ; Gruppuso PA; Ross J
    Oncogene; 1997 Mar; 14(11):1279-86. PubMed ID: 9178888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 8q24 Copy number gains and expression of the c-myc mRNA stabilizing protein CRD-BP in primary breast carcinomas.
    Ioannidis P; Mahaira L; Papadopoulou A; Teixeira MR; Heim S; Andersen JA; Evangelou E; Dafni U; Pandis N; Trangas T
    Int J Cancer; 2003 Mar; 104(1):54-9. PubMed ID: 12532419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER2 signaling enhances 5'UTR-mediated translation of c-Myc mRNA.
    Galmozzi E; Casalini P; Iorio MV; Casati B; Olgiati C; Ménard S
    J Cell Physiol; 2004 Jul; 200(1):82-8. PubMed ID: 15137060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The c-myc coding region determinant-binding protein: a member of a family of KH domain RNA-binding proteins.
    Doyle GA; Betz NA; Leeds PF; Fleisig AJ; Prokipcak RD; Ross J
    Nucleic Acids Res; 1998 Nov; 26(22):5036-44. PubMed ID: 9801297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-MYC and IGF-II mRNA-binding protein (CRD-BP/IMP-1) in benign and malignant mesenchymal tumors.
    Ioannidis P; Trangas T; Dimitriadis E; Samiotaki M; Kyriazoglou I; Tsiapalis CM; Kittas C; Agnantis N; Nielsen FC; Nielsen J; Christiansen J; Pandis N
    Int J Cancer; 2001 Nov; 94(4):480-4. PubMed ID: 11745432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling.
    Noubissi FK; Elcheva I; Bhatia N; Shakoori A; Ougolkov A; Liu J; Minamoto T; Ross J; Fuchs SY; Spiegelman VS
    Nature; 2006 Jun; 441(7095):898-901. PubMed ID: 16778892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of GLI1 Expression by Targeting the CRD-BP-GLI1 mRNA Interaction Using a Specific Oligonucleotide.
    Mehmood K; Akhtar D; Mackedenski S; Wang C; Lee CH
    Mol Pharmacol; 2016 Jun; 89(6):606-17. PubMed ID: 27036131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs.
    Weidensdorfer D; Stöhr N; Baude A; Lederer M; Köhn M; Schierhorn A; Buchmeier S; Wahle E; Hüttelmaier S
    RNA; 2009 Jan; 15(1):104-15. PubMed ID: 19029303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in RNA-binding activities of IRES-regulatory proteins as a mechanism for physiological variability and pathological dysregulation of IGF-IR translational control in human breast tumor cells.
    Meng Z; Jackson NL; Choi H; King PH; Emanuel PD; Blume SW
    J Cell Physiol; 2008 Oct; 217(1):172-83. PubMed ID: 18452152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.